29 November 2016
Sydney Vital is a cancer research Centre based in the Northern Local Health District and located in the Kolling Institute building, funded by the Cancer Institute NSW and the University of Sydney.
A panel of medical specialists, patient advocates and patients convened last week at The Sydney Vital Centre Conference 2016 (SVCC 2016) held at the Kolling Institute to discuss how does cancer research improve outcomes?
The SVCC 2016 attracted 165 patients and community, attendees also had the opportunity to learn more about modern discoveries in medicine and how technology can greatly influence cancer control.
SVCC 2016 Keynote speaker Professor Sean Grimmond from the University of Melbourne Centre for Cancer Research lead the great debate - Why do normal cells transform to cancer cells and how cancer treatment will change in the next 5 or 10 years?
Professor Grimmond leads Australia’s largest genome research effort into Cancer genome sequencing, stranscriptone analysis of disease and development of tools genome analysis.
Over the last 20 years, Professor Grimmond’s research has focused on uncovering the underlying genetics controlling key biological processes and tissue repair and cancer through pioneering efforts in genomics and transcriptomics.
Other speakers on the day included; Professor Stephen Clarke, Associate Professor Alexander Engel, Mrs Helen Jones (community representative), Professor Dale Bailey, Associate Professor Melanie Lovell, Professor Anthony Gill and Associate Professor Thomas Eade.